- Home
- SND vs ANVS Comparison
SND vs ANVS Comparison
Compare SND & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SND | ANVS |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.3M | 111.3M |
| IPO Year | 2016 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SND | ANVS |
|---|---|---|
| Price | $3.86 | $3.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $13.50 |
| AVG Volume (30 Days) | 515.7K | ★ 606.4K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | ★ 3.94% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $335,471,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $38.15 | ★ N/A |
| Revenue Growth | ★ 18.98 | N/A |
| 52 Week Low | $1.76 | $1.11 |
| 52 Week High | $4.51 | $5.57 |
Technical Indicators
Market Signals| Indicator | SND | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 54.73 | 57.18 |
| Support Level | $3.72 | $3.26 |
| Resistance Level | $4.26 | $3.72 |
| Average True Range (ATR) | 0.27 | 0.25 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 56.06 | 95.54 |
Price Performance
Historical ComparisonAbout SND Smart Sand Inc.
Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.